May 12, 2009 ... Morse, Esquire, Elena C. Norman, Esquire, Emily V. Burton, Esquire, YOUNG ... Defendant Amylin Pharmaceuticals, Inc. is a publicly traded Delaware ..... L.L.C. et al. ... 16 Amylin Pharmaceuticals, Inc., Definitive Proxy Statement of Carl C. Icahn et al. ... (S.D.N.Y. 2001) (citing U.S. Trust Co. of New York v.
Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability. February 6, 2017 | California Southern Dillon v. Amylin Pharmaceuticals, LLC et al.
Aug 26, 2013 ... Ralph Thibodeaux v. Amylin Pharmaceuticals, LLC, et al., C.A. No. ... Jerome Goldwire, et al. v. Merck & Co., Inc., et ... Vernie Young v. Amylin ...
May 11, 2016 ... Amylin Pharmaceuticals, LLC, et al., (14cv0056) Marble v. ... directed at particular patient groups, such as pediatric or young adult patients.
Apr 18, 2012 ... Re: Icahn Partners LP v. Amylin Pharmaceuticals, Inc. ... Bylaw") of Defendant Amylin Pharmaceuticals, Inc. (Iamylin" or the. Icompany") in ...
Amylin Pharmaceuticals, Inc., 2009 WL 4351698 (Del. Ch.) Four Seasons Resort Estates Homeowners Association Limited v. Hotel Equity Fund V, LLC, et al.
Oct 22, 2013 ... Pseudoprolines were purchased from Genzyme Pharmaceuticals. ..... Medicine facility at Amylin Pharmaceuticals, LLC for assistance with animal care, and Andrew Young .... Young A, editor (2005) Amylin: physiology and pharmacology. ... Day JW, Gelfanov V, Smiley D, Carrington PE, Eiermann G et al.
Sep 8, 2016 ... Merck Sharp & Dohme Corp., et al., No. ... 6 reply brief (In Re: Incretin-Based Therapies Products Liability Litigation, Jean Adams, et al. v. ... made by defendant Amylin Pharmaceuticals LLC and co-promoted by AstraZeneca ... of DLA Piper in Philadelphia; and Christopher Young of DLA Piper in San Diego.
Correspondence to: David G. Parkes, PhD, Amylin Pharmaceuticals, LLC, 9625 Towne. Centre Drive .... HbA1c versus vehicle at study end (Figure 2A); all treatment groups had ... Han et al. reported that oral dapagliflozin produced a 400-fold increase in .... Copley K, McCowen K, Hiles R, Nielsen LL, Young A, Parkes DG.
Dec 9, 2013 ... V-Lepob/J (ob/ob) mice (Jackson Laboratories, Bar Harbor, ME, USA; body weight 43 ± 1 g) were used. .... Han et al. reported that oral dapagliflozin produced a 400-fold increase ... All authors held stock in Amylin Pharmaceuticals , LLC. ... 9 Copley K, McCowen K, Hiles R, Nielsen LL, Young A, Parkes DG.